日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crosstalk between TGF-β and Wnt/β-catenin signaling drives fibrogenic and stem-like phenotypes in senescent MDA-MB-231 breast cancer cells.

TGF-β 和 Wnt/β-catenin 信号之间的串扰驱动衰老 MDA-MB-231 乳腺癌细胞的纤维化和干细胞样表型。

El Samarji Mona, Alam Elissa, Dakramanji Mariam, Bassam Mariam, Santina Jana, Ayoub Marc, Aprahamian Alex, Rima Mohamad

Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate

开发一种用于用肌醇三焦磷酸治疗的肝细胞特异性 Trim24 基因敲除小鼠体内跟踪肝细胞癌的方法

Mihaela Ignat, Cherif Youssef Akladios, Véronique Lindner, Konstantin Khetchoumian, Marius Teletin, Didier Muttter, Pierre Marc Aprahamian, Jacques Marescaux

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer

溶瘤细小病毒 H-1PV 与吉西他滨在胰腺癌中互补诱导免疫原性细胞死亡

Assia L Angelova, Svitlana P Grekova, Anette Heller, Olga Kuhlmann, Esther Soyka, Thomas Giese, Marc Aprahamian, Gaétan Bour, Sven Rüffer, Celina Cziepluch, Laurent Daeffler, Jean Rommelaere, Jens Werner, Zahari Raykov, Nathalia A Giese

Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas

丙戊酸与溶瘤细小病毒 H-1PV 的协同作用可作为治疗宫颈癌和胰腺癌的潜在疗法

Junwei Li, Serena Bonifati, Georgi Hristov, Tiina Marttila, Séverine Valmary-Degano, Sven Stanzel, Martina Schnölzer, Christiane Mougin, Marc Aprahamian, Svitlana P Grekova, Zahari Raykov, Jean Rommelaere, Antonio Marchini

Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies

溶瘤大鼠细小病毒 H-1PV,人类淋巴瘤的治疗候选药物:体外和体内研究

Assia L Angelova, Marc Aprahamian, Ginette Balboni, Henri-Jacques Delecluse, Regina Feederle, Irina Kiprianova, Svitlana P Grekova, Angel S Galabov, Mathias Witzens-Harig, Anthony D Ho, Jean Rommelaere, Zahari Raykov